Global liver cancer sector hits US$3.36 billion in 2024, targeting US$13.16 billion by 2033 at 16.5% CAGR. Uncover trends in TACE combinations, Asia-Pacific's fastest growth, and approvals like Opdivo + Yervoy driving solutions for advanced HCC. https://finance.yahoo.com/news/liver-cancer-therapeutics-market-size-140100776.html